Skip to main content
. Author manuscript; available in PMC: 2010 Feb 3.
Published in final edited form as: J Mol Med (Berl). 2005 Aug 26;83(11):917–926. doi: 10.1007/s00109-005-0700-2

Figure 3.

Figure 3

Ribonuclease Protection Assay (RPA) demonstrating the presence of both the wild-type and the EGFRvIII transcript. A813 is a 4th passage of xenograft with an amplified and rearranged EGFR gene, which mainly express the EGFRvIII transcript. GB182 is a GB without amplification of the EGFR gene but that express the EGFRvIII transcript, as is demonstrated here. GB180 and AA108 are tumours with EGFR amplification that only express the wild-type transcript.